citalopram has been researched along with vilazodone hydrochloride in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 12 (92.31) | 24.3611 |
2020's | 1 (7.69) | 2.80 |
Authors | Studies |
---|---|
Mandrioli, R; Mercolini, L; Raggi, MA; Saracino, MA | 1 |
Bhattaram, A; Huang, SM; Mehrotra, N; Wang, Y | 1 |
Seyfried, CA; van Amsterdam, C | 1 |
Brignone, M; Ereshefsky, L; Francois, C; Lançon, C; Llorca, PM; Rive, B; Salah, S | 1 |
Chen, D; Gommoll, C; Khan, A; Mathews, M; Nunez, R | 1 |
Chen, D; Clayton, AH; Gommoll, C; Mathews, M; Nunez, R | 1 |
Bundgaard, C; Eneberg, E; Sánchez, C | 1 |
Banerjee, P; Chan, JS; Choi, YK; Olivier, B; Oosting, RS; Tarazi, F | 1 |
Citrome, L | 1 |
Grant, JE; Leppink, EW; Redden, SA | 1 |
Casavant, MJ; Chounthirath, T; Russell, JL; Spiller, HA | 1 |
Fuller, RR; Hughes, S; Lacasse, J; Spaulding-Givens, J | 1 |
Badcock, PB; Bailey, AP; Cox, GR; Hetrick, SE; McKenzie, JE; Meader, N; Merry, SN; Moller, CI; Sharma, V | 1 |
4 review(s) available for citalopram and vilazodone hydrochloride
Article | Year |
---|---|
Selective serotonin reuptake inhibitors (SSRIs): therapeutic drug monitoring and pharmacological interactions.
Topics: Benzofurans; Citalopram; Depressive Disorder; Drug Monitoring; Fluoxetine; Fluvoxamine; Humans; Indoles; Paroxetine; Piperazines; Selective Serotonin Reuptake Inhibitors; Sertraline; Vilazodone Hydrochloride | 2012 |
Relative efficacy and tolerability of vortioxetine versus selected antidepressants by indirect comparisons of similar clinical studies.
Topics: Acetamides; Adult; Aged; Antidepressive Agents; Benzofurans; Citalopram; Cyclohexanols; Depressive Disorder, Major; Desvenlafaxine Succinate; Duloxetine Hydrochloride; Female; Humans; Hypnotics and Sedatives; Indoles; Male; Middle Aged; Piperazines; Selective Serotonin Reuptake Inhibitors; Sertraline; Sulfides; Thiophenes; Venlafaxine Hydrochloride; Vilazodone Hydrochloride; Vortioxetine | 2014 |
Vortioxetine for major depressive disorder: An indirect comparison with duloxetine, escitalopram, levomilnacipran, sertraline, venlafaxine, and vilazodone, using number needed to treat, number needed to harm, and likelihood to be helped or harmed.
Topics: Adult; Antidepressive Agents; Citalopram; Depressive Disorder, Major; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride; Vilazodone Hydrochloride | 2016 |
New generation antidepressants for depression in children and adolescents: a network meta-analysis.
Topics: Adolescent; Antidepressive Agents; Bias; Child; Citalopram; Depressive Disorder, Major; Desvenlafaxine Succinate; Duloxetine Hydrochloride; Female; Fluoxetine; Humans; Male; Mirtazapine; Network Meta-Analysis; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Suicidal Ideation; Venlafaxine Hydrochloride; Vilazodone Hydrochloride; Vortioxetine | 2021 |
3 trial(s) available for citalopram and vilazodone hydrochloride
Article | Year |
---|---|
Efficacy and safety of vilazodone 20 and 40 mg in major depressive disorder: a randomized, double-blind, placebo-controlled trial.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Benzofurans; Citalopram; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Indoles; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Treatment Outcome; Vilazodone Hydrochloride; Young Adult | 2015 |
Sexual dysfunction during treatment of major depressive disorder with vilazodone, citalopram, or placebo: results from a phase IV clinical trial.
Topics: Adult; Antidepressive Agents, Second-Generation; Citalopram; Depressive Disorder, Major; Double-Blind Method; Drug Partial Agonism; Female; Humans; Male; Middle Aged; Risk Assessment; Risk Factors; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT1 Receptor Agonists; Sexual Behavior; Sexual Dysfunction, Physiological; Sexual Dysfunctions, Psychological; Surveys and Questionnaires; Time Factors; Treatment Outcome; United States; Vilazodone Hydrochloride | 2015 |
Double-blind switch study of vilazodone in the treatment of major depressive disorder.
Topics: Adult; Citalopram; Depressive Disorder, Major; Double-Blind Method; Drug Resistance; Female; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Vilazodone Hydrochloride; Young Adult | 2017 |
6 other study(ies) available for citalopram and vilazodone hydrochloride
Article | Year |
---|---|
Is this the dose for you?: the role of modeling.
Topics: Age Factors; Antidepressive Agents; Benzofurans; Citalopram; Dose-Response Relationship, Drug; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Indoles; Models, Theoretical; Piperazines; Propylene Glycols; Risk Assessment; Sphingosine; Vilazodone Hydrochloride | 2013 |
Mechanism of action of the bimodal antidepressant vilazodone: evidence for serotonin1A-receptor-mediated auto-augmentation of extracellular serotonin output.
Topics: 5-Hydroxytryptophan; 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antidepressive Agents; Benzofurans; Brain; Citalopram; Dose-Response Relationship, Drug; Drug Interactions; Extracellular Space; Fluoxetine; Indoles; Male; Paroxetine; Piperazines; Pyridines; Rats, Wistar; Receptor, Serotonin, 5-HT1A; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin 5-HT1 Receptor Agonists; Serotonin Antagonists; Serotonin Receptor Agonists; Vilazodone Hydrochloride | 2014 |
P-glycoprotein differentially affects escitalopram, levomilnacipran, vilazodone and vortioxetine transport at the mouse blood-brain barrier in vivo.
Topics: Animals; Antidepressive Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Blood-Brain Barrier; Brain Chemistry; Cerebral Cortex; Citalopram; Cyclopropanes; Male; Mice; Milnacipran; Piperazines; Serotonin Plasma Membrane Transport Proteins; Sulfides; Vilazodone Hydrochloride; Vortioxetine | 2016 |
Differential effects of vilazodone versus citalopram and paroxetine on sexual behaviors and serotonin transporter and receptors in male rats.
Topics: Animals; Antidepressive Agents; Brain; Citalopram; Male; Paroxetine; Rats; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Sexual Behavior; Vilazodone Hydrochloride | 2016 |
Pediatric ingestion of vilazodone compared to other selective serotonin reuptake inhibitor medications.
Topics: Child; Child, Preschool; Citalopram; Coma; Dose-Response Relationship, Drug; Evidence-Based Medicine; Female; Fluoxetine; Fluvoxamine; Follow-Up Studies; Hospitalization; Humans; Infant; Male; Paroxetine; Poison Control Centers; Retrospective Studies; Seizures; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Vilazodone Hydrochloride | 2017 |
Adverse effects and treatment satisfaction among online users of four antidepressants.
Topics: Affective Symptoms; Antidepressive Agents; Citalopram; Duloxetine Hydrochloride; Humans; Internet; Mental Disorders; Patient Satisfaction; Piperazines; Sulfides; Vilazodone Hydrochloride; Vortioxetine | 2017 |